EGFR and skin basal cell carcinoma: In summary, nine gene signatures (CYFIP2, HOXB5, EGFR, FOXN3, PTPN3, CDC20, MARCKSL1, FAS, and PTCH1) may play central roles in the initiation and progression of BCC, which provides deeper insights into BCC management.